S&P Futures
3,926.25 +28.50 (+0.73%) Dow Futures
31,382.00 +180.00 (+0.58%) Nasdaq Futures
11,994.75 +116.50 (+0.98%) Russell 2000 Futures
1,792.20 +17.30 (+0.97%) Crude Oil
110.85 -1.36 (-1.21%) Gold
1,838.80 -2.40 (-0.13%)
InterCure Ltd. (INCR)
After hours:
Chart Events
Performance Outlook
| Previous Close | 7.28 |
| Open | 7.15 |
| Bid | 6.39 x 1100 |
| Ask | 7.32 x 1100 |
| Day's Range | 7.07 - 7.33 |
| 52 Week Range | 4.50 - 8.77 |
| Volume | |
| Avg. Volume | 60,777 |
| Market Cap | 328.123M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.08 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for INCR
Related Research
- Intercure Ltd.HSKA: Raising target price to $105.00HESKA CORP has an Investment Rating of HOLD; a target price of $105.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.RatingFair ValueEconomic Moat2 days agoArgus Research
- Motley Fool
InterCure (Class A) (INCR) Q1 2022 Earnings Call Transcript
Thank you for standing by, and welcome to the InterCure first quarter 2022 earnings call and webcast. A copy of the company's earnings press release is available on the News and Events section of our website at www.intercure.co. With me on today's call are Alex Rabinovich, InterCure's chief executive officer, and Amos Cohen, the company's chief financial officer.
- GlobeNewswire
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
Quarterly revenues Quarterly revenues Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2 million in Q1 of 2021 Seventh consecutive quarter of positive cash flow from operations $91 million cash on March 31, 2022 Revenue growth expected to continue in the second quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel , May 16, 2022 (GLOBE NEWSWIRE)
- GlobeNewswire
InterCure to Release its Q1 2022 Results and Hold a Conference Call
Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ETNEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the first quarter of 2022 after market close on Monday, May 16, 2022. The Company will conduct a conference call on Tuesday, May 17, 2022, at 8:00a.m. (Eastern Time) to review the results as well
